THE Therapeutic Goods Administration has confirmed the timeline for a consultation on options for handling complaints about therapeutic goods advertising, with plans to initiate the formal discussion this month.
The imminent review was flagged at last week's Australian Self-Medication Industry conference by TGA chief John Skerritt (PD Fri).
The advertising and complaints processes consultation is one of a number of consultations planned for Nov release.
Other consultations this month include a priority review of accelerated assessment of medical devices, and designation of Australian conformity assessment bodies for medical devices.
The new year will see a range of regulatory reforms relating to complementary medicines (CMs).
A new class of assessed CMs will be introduced and mechanisms for establishing a list of permitted indications will be defined.
This will include consultation on the criteria around indications issues while criteria for publication of claims on promotional material and incentives for innovation will also be explored - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Nov 16
